BSEBoard Meeting3d ago · 28 Jul 2026, 05:52 pm
Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 ,inter alia, to consider and approve 1. Unaudited Standalone ....
Vivanza Biosciences Ltd · 530057
✦ AI SummaryResults
Vivanza Biosciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 to consider and approve unaudited standalone and consolidated financial results along with limited review report for the quarter ended on June 30, 2026.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Vivanza Biosciences Ltd - 530057 - Board Meeting Intimation for The Consideration And Approval Of The Quarterly Financial Result Ended On 30Th June, 2026.
Attachments (1)
📄pdf
Download →
4cb3c9aa-8706-4819-a946-614becbe6ae9.pdf
View document text
VIVANZA BIOSCIENCES LIMITED
Regd. Office: 403, Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054.
Phone: 079-26870953, email: info@vivanzabiosciences.com, website: www.vivanzabiosciences.com
CIN: L24105GJ1982PLC005057
Date: 28th July, 2026
Department of Corporate Services,
BSE Limited,
Ground Floor, P. J. Towers,
Dalal Street,
Mumbai – 400001,
Scrip Code: 530057 ISIN: INE984E01035
Subject: Intimation for the meeting of the Board of Directors pursuant to Regulation 29, 30 and
Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015
Dear Sir/Madam,
Pursuant to Regulation 29, 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors of the
Company is scheduled to be held on Saturday, August 01, 2026, at 03:30 P.M. at the Registered Office of the
Company to consider and approve the following items:
1. Unaudited Standalone and Consolidated Financial Results along with Limited Review Report of the
Company for the Quarter ended on June 30, 2026;
2. Take note of the Notice of Disclosure of Interest and Intimation u/s 164 of the Companies Act, 2013
3. Take note of Declarations from Independent Directors U/S 149(7) of The Companies Act, 2013
4. Any other business with the permission of the chair;
As per Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
Intimation of the Board meeting would be made available on the website of the company at:
https://vivanzabiosciences.com/announcement/
Further, as already informed, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended
from time to time, and Company's Internal Code for Prohibition of Insider Trading ('Code'), the trading
window for dealing in the securities of the Company for the Directors/Officers & Key Managerial Personnel
and Designated Persons of the Company defined under the Code has already been closed till the expiry of 48
hours after the declaration of Audited Financial Results for the Quarter and Year ended 30th June, 2026.
We request you to take the same on record.
Thanking you
For Vivanza Biosciences Limited
JAYENDRA MEHTA
MANAGING DIRECTOR
DIN: 08210602